Skip to search formSkip to main contentSkip to account menu

AIDSVAX

Known as: ALVAC-HIV, vCP1521 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

AIDS Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Could vaccination with AIDSVAX immunogens have resulted in antibody-dependent enhancement of HIV infection in human subjects?
The immune-correlate analysis of the RV144 clinical trial revealed that human plasma IgA immune responses elicited by the RV144… 
2013
2013
Challenges in clinical trial design for HIV-1 cure research
2011
2011
The potential impact of an HIV vaccine with limited protection on HIV incidence in Thailand: a modeling study.
2011
2011
The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand.
Review
2004
Review
2004
AIDSVAX VaxGen.
AIDSVAX, a bivalent vaccine consisting of a preparation of recombinant gp120 from two types of HIV, is being developed by VaxGen… 
2003
2003
Making sense of AIDSVAX.
Preliminary data from the manufacturer of AIDSVAX presented in a February press conference indicate overall disappointing results… 
Review
2001
Review
2001
AIDSVAX. VaxGen.
AIDSVAX, a bivalent vaccine consisting of a preparation of recombinant gp120 from two types of HIV, is being developed by VaxGen… 
2000
2000
AIDSVAX (MN) in Bangkok injecting drug users: a report on safety and immunogenicity, including macrophage-tropic virus neutralization.
A randomized, double-blind, placebo-controlled phase I/II study of AIDSVAX (MN) was conducted among injecting drug users in… 
Review
1999
Review
1999
New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview.
Review
1998
Review
1998
Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.
AIDSVAX (VaxGen, Inc., South San Francisco, CA), a possible vaccine to protect against human immunodeficiency virus type 1 (HIV-1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)